期刊文献+

卒中单元对卒中患者二级预防依从性的影响 被引量:1

Effects of Stroke Unit on the Compliance of Secondary Prevention in Patients with Stroke
原文传递
导出
摘要 目的:探讨卒中单元对卒中患者卒中发病后1年时二级预防依从性的影响。方法:采用回顾性研究设计,研究对象为在卒中单元(500例)和普通病房(445例)接受治疗的卒中或短暂性脑缺血发作患者。卒中单元组通过到院随访、电话随访或人户随访1年,普通病房组通过电话随访1年。观察指标为:抗栓药物的使用率、戒烟人数比率、卒中早期症状知晓率和患者自身卒中危险因素知晓率。结果:(1)卒中单元组抗栓药物使用率为92.76%,显著高于普通病房组的51.49%(P〈0.01);(2)卒中单元组戒烟人数比率、卒中早期症状知晓率和自身危险因素知晓率分别为82.33%、91.04%和94.03%,显著高于普通病房组的54.75%、65.53%和70.37%(P均〈0.01)。结论:卒中单元重视卒中的二级预防和强调规范化治疗,显著提高卒中患者二级预防的依从性。 Objective: To investigate the impact of stroke unit (SU) on the compliance of secondary prevention in patients with stroke at 12 months after stroke. Methods: Research subjects were stroke patients who were treated in SU (n = 500) and in general ward (GW) (n = 445) using a design of retrospective study. The patients in the SU group were followed up by hospital, telephone and home interviews for 12 months, and the patients in the GW group were followed up by telephone interview for 12 months. The main outcome measures were the rate of using antithrombotics, the rate of smoking cessation, and the rates of awareness of early stroke symptom and stroke risk factors of patients. Results: he rate of using antithrombotics was 92.76% in the SU group, and it was significantly higher than 51.49% in the GW group (P 〈 0.01); the rate of smoking cessation, and the rates of awareness of early stroke symptom and stroke risk factors of patients were 82.33%, 91.04%, and 94.03% respectively in the SU group, and they were significantly higher than 54.75%, 6.53%, and 70.37% in the GW group (P all 〈 0.01 ). Conclusions: SU attaches importance to the secondary stroke prevention and emphasizes standardized treatment, and the compliance of the secondary stroke prevention in patient with stroke is improved significantly.
出处 《国际脑血管病杂志》 2008年第4期277-279,共3页 International Journal of Cerebrovascular Diseases
关键词 卒中 卒中单元 二级预防 依从性 stroke unit stroke secondary prevention compliance
  • 相关文献

参考文献10

  • 1Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol, 2007, 6:456 -464.
  • 2Shi FL, Hart RG, Sherman DG, et al. Stroke in the People's Republic of China. Stroke, 1989, 20:1581 - 1585.
  • 3Rothwell PM. Lack of epidemiological data on secondary stroke prevention. Lancet Neurol, 2005, 4:518 - 519.
  • 4Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev, 2002: CD000197.
  • 5Lee AH, Somerford P J, Yau KK. Risk factors for ischaemic stroke recurrence after hospitalisation. Med J Aust, 2004, 181:244 -246.
  • 6北京神经病学学术沙龙.BNC脑血管病临床指南[M].北京:人民卫生出版社,2002..
  • 7王家良,主编.临床流行病学-临床科研设计、衡量与评价.上海:上海科学技术出版社,2002
  • 8Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37:577 -617.
  • 9Hamann GF, Weimar C, Glahn J, et al. Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank. Cerebrovasc Dis, 2003, 15:282 -288.
  • 10Zhang XF, Attia J, D'Este C, et al. Prevalence and magnitude of classical risk factors for stroke in a cohort of 5 092 Chinese steelworkers over 13. 5 years of follow-up. Stroke, 2004, 35:1052 - 1056.

共引文献33

同被引文献11

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部